UK Trade Minister visits GlaxoSmithKline Pakistan

Image
Islamabad: September 21, 2017. (PCP) As a part of his three-day visit to Pakistan, the UK Minister for Trade Policy Greg Hands visited GlaxoSmithKline’s factory in Karachi to see first-hand how major British investors, like GSK, are successfully doing business in Pakistan, supporting the Pakistani economy and creating jobs whilst making good returns on investment. Whilst touring the state of the art facility at F268 S.I.T.E area, the minister heard first-hand how GlaxoSmithKline (GSK) Pakistan, created in 2001, stands today as the largest pharmaceutical company in Pakistan, making a difference to people’s lives every day and employing over 2300 people in Pakistan. The Minister of State for Trade Policy, Greg Hands, said: "As I've seen on my visit, its clear Pakistan presents huge opportunities for UK businesses with its infrastructure investment and growing consumer base. GSK has long recognised that potential, employing 2,300 people here in Karachi and throughout Pakistan and exporting pharmaceuticals across the region. "By doubling the financial support available to UK companies to help them do business in Pakistan to £400 million, through UK Export Finance (UKEF), the UK government is determined to help more British business seize the many opportunities here." Minister Hands visited GSK as a part of a three day visit to Islamabad and Karachi in a bid to strengthen the UK-Pakistan bilateral trade relationship. The minister received a tour of the state of the art facility and heard GSK’s vaccine has been in use in Pakistan EPI’s National Immunization Program since 2012, protecting millions of newborns against pneumonia since then, a second vaccine has been introduced in the program (in 2016) for Rotavirus Diarrhea. GSK is a long established investor in Pakistan. GSK’s legacy company Glaxo Laboratories Pakistan Ltd. was the first pharmaceutical company to be listed on the Karachi Stock Exchange in 1951. GSK Pakistan operates mainly in two industry segments: Pharmaceuticals (prescription drugs and vaccines) and consumer healthcare (over-the-counter-medicines, oral care and nutritional care). In Pakistan, the Company deals in Anti-infective, Respiratory, Vaccines, Dermatological, Gastrointestinal, Analgesics, Urology, Central Nervous System, Allergy, Cardiovascular and Vitamins therapy areas.

You May Also Like

Image

A Breakthrough for RAAC Families: The Early Support Scheme Secured After Campaign Pressure. Report by Wilson Chowdhry

UK: Months on from a major breakthrough, the UK RAAC Campaign Group hopes affected homeowners are now benefiting from vita

Image

IDC Applauds Trump-Aoun Meeting; Calls for Restoration of Lebanese Sovereignty and Lasting Regional Peace

Washington, DC: In Defense of Christians (IDC), America’s leading advocacy organization for Christians in the Middle East, welcomes yest

Image

Statehood and Self-determination are Fundamentally Different: WKAF

Washington, D.C: The demonstration in New Delhi demanding the restoration of statehood for Jammu and Kashmir, led by the National Confere

"Trial of Pakistani Christian Nation" By Nazir S Bhatti

On demand of our readers, I have decided to release E-Book version of "Trial of Pakistani Christian Nation" on website of PCP which can also be viewed on website of Pakistan Christian Congress www.pakistanchristiancongress.org . You can read chapter wise by clicking tab on left handside of PDF format of E-Book.

nazirbhattipcc@aol.com , pakistanchristianpost@yahoo.com